Patents by Inventor Mary Maxon

Mary Maxon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090075327
    Abstract: The invention relates to the production of secondary metabolites by fungi. More particularly, the invention relates to improvement of production of commercially important secondary metabolites by fungi. The invention provides methods for improving secondary metabolite production in a fungus, comprising modulating the expression of a gene involved in regulation of secondary metabolite production.
    Type: Application
    Filed: March 7, 2001
    Publication date: March 19, 2009
    Inventors: Robert Busby, Brian Cali, Peter Hecht, Doug Holtzman, Kevin Madden, Mary Maxon, Todd Milne, Thea Norman, John Royer, Sofie Salama, Amir Sherman, Jeff Silva, Eric Summers
  • Patent number: 7229784
    Abstract: Methods for improving the production of a secondary metabolite by a fungus by increasing the yield or productivity of the secondary metabolite produced by the fungus are described. The methods include increasing the expression of LYS14, for example, by transforming a cell with a nucleic acid molecule encoding LYS14.
    Type: Grant
    Filed: September 19, 2001
    Date of Patent: June 12, 2007
    Assignee: Microbia, Inc.
    Inventors: Douglas Holtzman, Kevin T. Madden, Mary Maxon, Amir Sherman
  • Publication number: 20060263864
    Abstract: Methods for improving secondary metabolite production by modulating certain genes involved in secondary metabolite production, including genes encoding CreA, AreA, GanB, Gna3, FadA, Gna1, Gpa1, RfeH, An09, PacC, Lys14, LovU, Ste7, Pde2, Nc1, Vps34 and fungal homologs thereof.
    Type: Application
    Filed: December 3, 2002
    Publication date: November 23, 2006
    Inventors: Robert Busby, Brian Cali, Peter Hecht, Douglas Holtzman, Kevin Madden, Mary Maxon, G. Milne, Thea Norman, John Royer, Jeff Silva, Eric Summers, Lixin Zhang, Maria Mayorga, Toby Feibelman, Reed Doten
  • Publication number: 20050273271
    Abstract: An image analysis method characterizes cells based on the elongation. It analyzes an image of the cells and automatically identifies points or locations of high contrast (i.e., regions where the transition from intense signal to weak signal occurs abruptly, over a short distance). Groups of contiguous high contrast points collectively define a putative cell edge. Identified edges are then analyzed to determine whether they are elongated. In one example, edges with relatively low curvature are deemed elongated. The curvature analysis may be accomplished by calculating a shape descriptor for each edge (e.g., calculating the circular variance for each edge). One or more stages of the analysis may employ some degree of filtering, smoothing or other processing to remove certain artifacts in the image.
    Type: Application
    Filed: April 1, 2005
    Publication date: December 8, 2005
    Inventors: Aibing Rao, David Roof, Mary Maxon, Eugeni Vaisberg
  • Patent number: 6949356
    Abstract: The invention relates to the production of secondary metabolites by fungi. More particularly, the invention relates to improvement of production of commercially important secondary metabolites by fungi. The invention provides methods for improving secondary metabolite production in a fungus, comprising modulating the expression of a gene involved in regulation of secondary metabolite production.
    Type: Grant
    Filed: January 19, 2000
    Date of Patent: September 27, 2005
    Assignee: Microbia, Inc.
    Inventors: Robert Busby, Brian Cali, Peter Hecht, Doug Holtzman, Kevin Madden, Mary Maxon, Todd Milne, Thea Norman, John Royer, Sofie Salama, Amir Sherman, Jeff Silva, Eric Summers
  • Patent number: 6905840
    Abstract: Provided are methods of identifying potential antifungal agents, and particularly those having antimitotic activity. Fungal cells having double mutations which alter microtubule stability and inhibit cell proliferation are used in the methods. Test compounds are screened to identify those which are able to promote cell proliferation o the mutant fungal cells and counteract the stabilizing effect of the double mutations on the microtubules. High-throughput methods of selecting for the novel antifungal agents are also provided.
    Type: Grant
    Filed: April 14, 2003
    Date of Patent: June 14, 2005
    Assignee: Cytokinetics, Inc.
    Inventors: David M. Roof, Mary Maxon
  • Publication number: 20040203006
    Abstract: The present invention provides isolated nucleic acid and amino acid sequences of Candida glabrata beta-tubulin, antibodies to C. glabrata beta-tubulin, and methods of screening to identify antifungals using biologically active C. glabrata beta-tubulin.
    Type: Application
    Filed: April 11, 2003
    Publication date: October 14, 2004
    Applicant: Cytokinetics, Inc.
    Inventors: Mary Maxon, David Clarke, Christophe Beraud
  • Publication number: 20020128250
    Abstract: The invention relates to the production of secondary metabolites by fungi. More particularly, the invention relates to improvement of production of commercially important secondary metabolites by fungi. The invention provides methods for improving secondary metabolite production in a fungus, comprising modulating the expression of a gene involved in regulation of secondary metabolite production.
    Type: Application
    Filed: March 7, 2001
    Publication date: September 12, 2002
    Inventors: Robert Busby, Brian Cali, Peter Hecht, Doug Holtzman, Kevin Madden, Mary Maxon, Todd Milne, Thea Norman, John Royer, Sofie Salama, Amir Sherman, Jeff Silva, Eric Summers